Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2006
Business Overview: The company manufactures and distributes disposable protective apparel, infection control products, extended care products (medical bed pads, pet beds), and engineered construction products (house wrap, roof underlayment, antimicrobial paint). Operations are conducted through four segments: Disposable Protective Apparel, Infection Control, Extended Care, and Engineered Products.
Key Financial Metrics
| Metric | Q1 2006 | Q1 2005 |
|---|---|---|
| Net Sales | $7,971,000 | $6,982,000 |
| Gross Margin | $3,641,000 (45.7%) | $3,161,000 (45.3%) |
| Operating Income | $1,034,000 | $686,000 |
| Net Income | $649,000 | $444,000 |
| Diluted EPS | $0.03 | $0.02 |
| Cash and Equivalents | $882,000 | $3,368,000 (End of Q1 2005) |
| Working Capital | $15,042,000 | N/A |
| Debt | $0 | $0 |
| Current Ratio | 7.26:1 | N/A |
Cash Flow Summary (Q1 2006): Net cash used in operating activities was $515,000. Net cash used in investing activities was $110,000. Net cash provided by financing activities was $344,000 (primarily from stock option exercises).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 14.2% ($989,000) year-over-year, driven by an 80.0% increase in the Engineered Products segment ($792,000 increase) and a 38.4% increase in Infection Control sales ($467,000 increase).
- Segment Performance:
- Engineered Products: Sales rose to $1,782,000 from $990,000. Gross margin improved to 29.5% from 20.6%.
- Infection Control: Sales rose to $1,683,000 from $1,216,000, attributed to strong N-95 respirator demand due to Avian Flu concerns.
- Disposable Protective Apparel: Sales declined 4.1% to $4,070,000 due to inventory reduction by a major distributor.
- Extended Care: Sales declined 18.2% to $436,000.
- Profitability: Net income increased 46.2% to $649,000. Operating income increased 50.7% to $1,034,000.
- Liquidity: Cash decreased by $281,000 to $882,000, primarily due to operating cash outflows and capital expenditures, partially offset by proceeds from stock option exercises.
Guidance, Outlook, and Risks
- Outlook: Management expects significant growth in the Engineered Products segment in 2006, with gross margins projected to reach the low-to-mid 30% range as the India joint venture facility becomes fully operational. The Infection Control segment is expected to remain strong if Avian Flu concerns persist.
- Joint Venture: The company holds a 41.66% interest in Harmony Plastics Private Limited (India). A $942,000 non-interest-bearing advance to the joint venture begins repayment in July 2006. The company recorded a $9,000 equity loss for the quarter due to intercompany profit eliminations.
- Capital Resources: The company has a $3.5 million credit facility with $3.184 million available; no borrowings were outstanding as of March 31, 2006. No debt exists.
- Risks:
- Concentration: Reliance on a major distributor for the Disposable Protective Apparel segment, which recently reduced inventory levels.
- Foreign Operations: Manufacturing in China, Mexico, and India exposes the company to foreign currency exchange rate fluctuations, though no hedging is currently employed.
- Inventory: High inventory levels in the Engineered Products segment are maintained to support anticipated sales growth.
- Accounting Changes: Adopted SFAS 123R (Share-Based Payment) effective Jan 1, 2006. No expense was recognized in Q1 2006 as there were no outstanding unvested awards at adoption.
Investor Verification Checklist
- Distributor Dependency: Verify the status of orders from the largest distributor in the Disposable Protective Apparel segment and the impact of their inventory normalization.
- Engineered Products Margins: Monitor the realization of projected gross margin improvements (low-to-mid 30%) in the Engineered Products segment as the India facility ramps up.
- Joint Venture Repayment: Track the commencement of the $942,000 advance repayment from the India joint venture starting July 2006.
- Avian Flu Impact: Assess the sustainability of the Infection Control segment's growth, which is currently driven by specific pandemic-related demand.
- Cash Burn: Review the trend of negative operating cash flow ($515,000 used in Q1) against the company's cash balance and credit facility availability.